Wealth Enhancement Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Wealth Enhancement Advisory Services's BMY Position: Q3 2026 in Review
Wealth Enhancement Advisory Services increased its Bristol-Myers Squibb (BMY) stake by 16% in Q3 2026, buying an estimated $18.4M and bringing the position to 2,055,817 shares worth $104M. The position accounts for 0.15% of the portfolio, ranked #115.
Wealth Enhancement Advisory Services first reported a position in BMY in Q2 2017 and has held it in 20 quarters since. 2,570 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Wealth Enhancement Advisory Services held 2,055,817 shares of Bristol-Myers Squibb worth $104M as of Q3 2026.
- Wealth Enhancement Advisory Services bought 291,122 Bristol-Myers Squibb shares in Q3 2026, an estimated $18.4M.
- Bristol-Myers Squibb made up 0.15% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #115 holding.
- Wealth Enhancement Advisory Services first reported a position in Bristol-Myers Squibb in Q2 2017 and has held it in 20 quarters since.
- 2,570 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.